Impact of Asthma Treatments on Daily Activities

This study is currently recruiting participants.

Verified by Ovation Research Group, July 2006

First Received: July 5, 2006 No Changes Posted

Sponsor:	Ovation Research Group
Collaborator:	Genentech
Information provided by:	Ovation Research Group
ClinicalTrials.gov Identifier:	NCT00350376

Purpose

The primary objective of this web-based, cross-sectional study is to assess and compare the ability to sleep, work or go to school, and to participate in leisure activities among subjects who are receiving Xolair treatment and subjects who were eligible to receive Xolair, but instead have been using Advair for at least 1 year.

Condition
Asthma Allergies

Study Type:	Observational
Study Design:	Cross-Sectional, Defined Population, Retrospective Study
Official Title:	Study on Asthma Treatments on Daily Activities as Reported by Patients (STAR)

Resource links provided by NLM:

MedlinePlus related topics: Allergy Asthma

U.S. FDA Resources

Further study details as provided by Ovation Research Group:

Estimated Enrollment:	1500
Study Start Date:	June 2006

Eligibility

Ages Eligible for Study:	18 Years to 55 Years
Genders Eligible for Study:	Both

Criteria

Inclusion Criteria:

Have asthma and allergies
Currently taking Xolair® or Advair®
Started Xolair® treatment within the last 4 to 12 months OR have been taking Advair® for at least 12 months
Between 18 and 55 years of age
A non-smoker for at least 6 months
Have internet access

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00350376

Contacts

Contact: Nita Ngo, MPH

888.631.9167

asthmastudy@ovation.org

Locations

United States, California
Ovation Research Group	Recruiting
San Francisco, California, United States, 94105
Principal Investigator: Susan D Mathias, MPH

Sponsors and Collaborators

Ovation Research Group

Genentech

Investigators

Principal Investigator:

Susan D Mathias, MPH

Ovation Research Group

More Information

No publications provided

Study ID Numbers:	1467
Study First Received:	July 5, 2006
Last Updated:	July 5, 2006
ClinicalTrials.gov Identifier:	NCT00350376 History of Changes
Health Authority:	United States: Institutional Review Board

Keywords provided by Ovation Research Group:

asthma
allergies
Xolair
Advair

Additional relevant MeSH terms:

Hypersensitivity
Lung Diseases, Obstructive
Immune System Diseases
Respiratory Tract Diseases
Bronchial Diseases

Lung Diseases
Hypersensitivity, Immediate
Asthma
Respiratory Hypersensitivity

ClinicalTrials.gov processed this record on February 08, 2010